Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
168 | Chinese Journal of Cancer Biotherapy | journal | 0.100 Q4 | 5 | 122 | 243 | 2977 | 3 | 240 | 0.01 | 24.40 | |
167 | VacciMonitor | journal | 0.101 Q4 | 5 | 24 | 22 | 451 | 0 | 21 | 0.00 | 18.79 | |
166 | Drugs in Context | journal | 0.107 Q4 | 36 | 13 | 3 | 461 | 0 | 3 | 0.00 | 35.46 | |
165 | Current Biomarkers | journal | 0.108 Q4 | 3 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
164 | Gene Therapy and Molecular Biology | journal | 0.121 Q4 | 18 | 18 | 12 | 644 | 3 | 12 | 0.25 | 35.78 | |
163 | Journal of Experimental Pharmacology | journal | 0.129 Q4 | 23 | 1 | 3 | 166 | 2 | 3 | 0.50 | 166.00 | |
162 | Gene Therapy and Regulation | journal | 0.131 Q4 | 7 | 0 | 17 | 0 | 6 | 15 | 0.45 | 0.00 | |
161 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.134 Q4 | 16 | 40 | 162 | 1707 | 47 | 162 | 0.23 | 42.68 | |
160 | Open Pharmacology Journal | journal | 0.139 Q4 | 6 | 4 | 10 | 130 | 7 | 10 | 0.33 | 32.50 | |
159 | Cellular Therapy and Transplantation | journal | 0.163 Q4 | 8 | 0 | 36 | 0 | 10 | 35 | 0.10 | 0.00 | |
158 | Nucleus (India) | journal | 0.164 Q4 | 17 | 25 | 31 | 808 | 11 | 30 | 0.35 | 32.32 | |
157 | Open Bioactive Compounds Journal | journal | 0.172 Q4 | 6 | 4 | 3 | 123 | 4 | 3 | 0.00 | 30.75 | |
156 | EXCLI Journal | journal | 0.199 Q4 | 55 | 95 | 145 | 3855 | 120 | 124 | 0.81 | 40.58 | |
155 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.199 Q4 | 29 | 12 | 34 | 1144 | 19 | 0 | 0.58 | 95.33 | |
154 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.206 Q4 | 14 | 16 | 85 | 1044 | 27 | 78 | 0.33 | 65.25 | |
153 | Journal of Biological Sciences (discontinued) | journal | 0.215 Q4 | 38 | 99 | 233 | 3673 | 163 | 233 | 0.54 | 37.10 | |
152 | Journal of Stem Cells | journal | 0.224 Q4 | 21 | 14 | 58 | 1245 | 32 | 58 | 0.40 | 88.93 | |
151 | Current Enzyme Inhibition | journal | 0.231 Q4 | 19 | 18 | 60 | 1416 | 41 | 55 | 0.51 | 78.67 | |
150 | Turkish Journal of Pharmaceutical Sciences | journal | 0.231 Q4 | 22 | 42 | 85 | 1194 | 44 | 85 | 0.53 | 28.43 | |
149 | Yaoxue Xuebao | journal | 0.231 Q4 | 36 | 272 | 773 | 7039 | 517 | 773 | 0.68 | 25.88 | |
148 | Current Cancer Therapy Reviews | journal | 0.236 Q4 | 17 | 26 | 101 | 2513 | 49 | 95 | 0.43 | 96.65 | |
147 | Current Pharmacogenomics and Personalized Medicine | journal | 0.262 Q4 | 20 | 38 | 103 | 1871 | 117 | 80 | 1.28 | 49.24 | |
146 | Pteridines | journal | 0.271 Q4 | 19 | 32 | 31 | 1342 | 24 | 31 | 0.90 | 41.94 | |
145 | Biomolecules and Therapeutics | journal | 0.272 Q4 | 56 | 70 | 211 | 2808 | 184 | 211 | 0.92 | 40.11 | |
144 | Expert Opinion on Medical Diagnostics | journal | 0.273 Q4 | 28 | 60 | 144 | 4380 | 154 | 141 | 1.11 | 73.00 | |
143 | Drug Discovery Today: Disease Models | journal | 0.288 Q4 | 33 | 34 | 76 | 1646 | 53 | 67 | 0.70 | 48.41 | |
142 | Current Pharmaceutical Analysis | journal | 0.294 Q4 | 27 | 44 | 108 | 1755 | 117 | 107 | 0.80 | 39.89 | |
141 | Letters in Drug Design and Discovery | journal | 0.294 Q4 | 37 | 131 | 375 | 3537 | 410 | 371 | 0.97 | 27.00 | |
140 | International Journal of Peptide Research and Therapeutics | journal | 0.302 Q4 | 45 | 44 | 117 | 1394 | 122 | 116 | 0.80 | 31.68 | |
139 | MCB Molecular and Cellular Biomechanics | journal | 0.326 Q4 | 31 | 16 | 52 | 553 | 47 | 52 | 0.91 | 34.56 | |
138 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.352 Q4 | 53 | 48 | 280 | 1434 | 303 | 280 | 1.07 | 29.88 | |
137 | Virologica Sinica | journal | 0.354 Q4 | 47 | 52 | 149 | 1665 | 150 | 145 | 1.14 | 32.02 | |
136 | Personalized Medicine | journal | 0.392 Q4 | 36 | 93 | 271 | 3420 | 289 | 214 | 0.98 | 36.77 | |
135 | Genetic Vaccines and Therapy | journal | 0.421 Q4 | 30 | 0 | 32 | 0 | 46 | 32 | 1.21 | 0.00 | |
134 | Journal of Asian Natural Products Research | journal | 0.442 Q4 | 51 | 171 | 504 | 3457 | 624 | 503 | 1.17 | 20.22 | |
133 | Drug Discovery Today: Therapeutic Strategies | journal | 0.453 Q3 | 31 | 22 | 62 | 1225 | 87 | 55 | 1.58 | 55.68 | |
132 | Probiotics and Antimicrobial Proteins | journal | 0.458 Q3 | 52 | 30 | 90 | 1282 | 117 | 89 | 1.12 | 42.73 | |
131 | Biotechnology and Applied Biochemistry | journal | 0.464 Q3 | 81 | 72 | 178 | 3206 | 337 | 175 | 1.65 | 44.53 | |
130 | SAR and QSAR in Environmental Research | journal | 0.471 Q3 | 54 | 58 | 124 | 2516 | 268 | 123 | 2.16 | 43.38 | |
129 | Pharmaceutical Biology | journal | 0.493 Q3 | 88 | 213 | 591 | 7772 | 1017 | 591 | 1.72 | 36.49 | |
128 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.495 Q3 | 45 | 26 | 75 | 2332 | 108 | 69 | 1.10 | 89.69 | |
127 | Current Computer-Aided Drug Design | journal | 0.511 Q3 | 32 | 52 | 84 | 3394 | 162 | 76 | 1.77 | 65.27 | |
126 | Journal of Biochemical and Molecular Toxicology | journal | 0.529 Q3 | 69 | 63 | 165 | 2668 | 263 | 164 | 1.46 | 42.35 | |
125 | Archives of Pharmacal Research | journal | 0.561 Q3 | 105 | 172 | 762 | 6423 | 1578 | 750 | 1.99 | 37.34 | |
124 | Molecular Medicine Reports | journal | 0.567 Q3 | 86 | 620 | 904 | 18366 | 1516 | 904 | 1.75 | 29.62 | |
123 | Pharmacogenomics and Personalized Medicine | journal | 0.572 Q3 | 37 | 16 | 33 | 996 | 73 | 33 | 2.68 | 62.25 | |
122 | Pharmaceuticals | journal | 0.590 Q3 | 87 | 72 | 352 | 7009 | 642 | 349 | 1.34 | 97.35 | |
121 | Future Cardiology | journal | 0.625 Q3 | 43 | 87 | 231 | 4941 | 366 | 214 | 1.74 | 56.79 | |
120 | Journal of Peptide Science | journal | 0.635 Q3 | 73 | 99 | 315 | 4180 | 573 | 310 | 1.96 | 42.22 | |
119 | Advances in Pharmacological Sciences | journal | 0.676 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®